Toxoplasmose-Nosode-Injeel

Toxoplasmose-Nosode-Injeel
D 15, D 30, D 200 ana partes.
Toxoplasmose-Nosode-Injeel forte
D 10, D 15, D 30, D 200 0.275 ml each.

Condition after recovery from fetopathia toxoplasmotica, especially physical and mental disturbances and retardation. Symptomatically for unbearable, intractable headaches, e.g. in excessive hypertonia, migraine, mental changes, e.g. conditions of depression following chronic encephalitis, enterocolitis, hepatitis, lienitis, myositis, orchitis and a few skin diseases of the papular type (erythema nodosum).

To be administered in general as intermediate injection in retoxic phases, e.g. when children are retarded in their development (for example, after retoxically treated influenza or angina), but also after retoxic treatment of these diseases in adulthood, however (delayed convalescence).